Applied Molecular Transport AMTI

$ 0.26 0.0%

Quarterly report 2023-Q3
added 11-09-2023

Applied Molecular Transport Balance Sheet 2011-2024 | AMTI

Annual Balance Sheet Applied Molecular Transport

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-56.5 M	-156 M	-	-12.7 M	-20.3 M	-	-	-	-	-	-	-
Long Term Debt	49 K	167 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	4.64 M	3.58 M	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	106 M	64.2 M	-	-	-	-	-	-	-
Total Current Liabilities	15.1 M	14.3 M	7.66 M	-	-	-	-	-	-	-	-	-
Total Liabilities	46.6 M	50.5 M	8.51 M	110 M	67.4 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-366 M	-240 M	-139 M	-72.8 M	-44.8 M	-	-	-	-	-	-	-
Total Assets	107 M	214 M	140 M	38.5 M	23.2 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	61.1 M	160 M	5.95 M	12.8 M	20.3 M	-	-	-	-	-	-	-
Book Value	60.8 M	164 M	132 M	-71.7 M	-44.1 M	-	-	-	-	-	-	-
Total Shareholders Equity	60.8 M	164 M	132 M	-71.7 M	-44.1 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Applied Molecular Transport

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	114 K	49 K	59 K	-	190 K	167 K	221 K	282 K	344 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.78 M	4.31 M	47.2 M	46.6 M	46.2 M	-	53.8 M	50.5 M	19.5 M	16.2 M	12.8 M	8.51 M	8.51 M	8.51 M	8.51 M	4.62 M	4.62 M	4.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-418 M	-411 M	-394 M	-366 M	-343 M	-	-282 M	-240 M	-209 M	-183 M	-160 M	-139 M	-139 M	-139 M	-139 M	-72.8 M	-72.8 M	-72.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	20 M	25 M	83.3 M	107 M	125 M	-	182 M	214 M	207 M	224 M	126 M	140 M	140 M	140 M	140 M	38.5 M	38.5 M	38.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	18.1 M	22.5 M	41.8 M	61.1 M	76 M	95.8 M	126 M	160 M	152 M	159 M	26.2 M	5.84 M	5.84 M	5.84 M	5.84 M	12.7 M	12.7 M	12.7 M	-	20.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	16.2 M	20.6 M	36.1 M	60.8 M	78.4 M	-	128 M	164 M	188 M	208 M	114 M	132 M	132 M	132 M	132 M	33.9 M	33.9 M	33.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	16.2 M	20.6 M	36.1 M	60.8 M	78.4 M	97.8 M	128 M	164 M	188 M	208 M	114 M	132 M	132 M	132 M	132 M	-71.7 M	-71.7 M	-71.7 M	-49.1 M	-44.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency